The Influence of Obesity and Insulin Sensitivity on Reward Processing and Decision Making
No acronym
2 other identifiers
interventional
50
0 countries
N/A
Brief Summary
Reward learning and decision-making processes, which operate largely outside of conscious control, shape food choices and eating behaviors. Excess adiposity is associated with differences in brain structure and functional connectivity underlying these processes, and insulin resistance, which commonly co-occurs with excess adiposity, has been linked with dopamine signaling that is crucial for these processes. However, whether and how excess adiposity and insulin resistance affect reward learning and decision-making remains poorly understood. This study will address that gap, examining the effects of excess adiposity and insulin resistance, and their interaction, on processes of reward learning and decision-making in food-specific and general contexts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
Study Completion
Last participant's last visit for all outcomes
July 1, 2029
June 10, 2026
June 1, 2026
3 years
May 28, 2026
June 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rated Liking
Participants will rate liking of flavors that will be paired with conditioned stimulus (CS) + and CS- drinks on a labeled hedonic scale during an enrollment session. In a post-test session, after all conditioning sessions have occurred, participants will rate liking of flavors that were previously paired with CS+ and CS- drinks.
On the first day of enrollment to the post-test session approximately 1-2 weeks later
Secondary Outcomes (2)
Rated Wanting
On the first day of enrollment to the post-test session approximately 1-2 weeks later
Proportion Correct on a Probabilistic Learning Task
Approximately 30-45 minutes during the enrollment/screening session at the start of the study
Study Arms (2)
Conditioned Stimulus- First, Then Conditioned Stimulus +
EXPERIMENTALParticipants will consume the Conditioned Stimulus (CS) - experimental drink 6 times during flavor-nutrient conditioning sessions. Then, they will consumes the CS+ experimental drink 6 times during flavor-nutrient conditioning sessions.
Conditioned Stimulus + First, Then Conditioned Stimulus -
EXPERIMENTALParticipants will consume the Conditioned Stimulus (CS) + experimental drink 6 times during flavor-nutrient conditioning sessions. Then, they will consumes the CS- experimental drink 6 times during flavor-nutrient conditioning sessions.
Interventions
Participants will consume flavored beverage solutions sweetened with sucralose and containing 110 calories of maltodextrin during 6 conditioning sessions.
Eligibility Criteria
You may qualify if:
- to 45 years of age
- Self-reported weight stable (within 5 lbs) for previous 3 months
- Not pregnant or planning to become pregnant during study participation
- Weigh more than 110 lbs (due to blood draws used in study)
- Residing in Roanoke, VA, area and/or willing to attend sessions at the Fralin Biomedical Research Institute
You may not qualify if:
- BMI \< 18.5 or \> 40 kg/m2
- Hemoglobin A1c \> 6.4%
- Fasting blood glucose \> 126 mg/dL
- hour blood glucose \> 200 mg/dL
- Self-reported current diagnosis of diabetes or other endocrine/metabolic disorder
- Self-reported current inhaled nicotine use
- Self-reported history of alcohol dependence
- Self-reported use of medications known to influence study measures (including antiglycemic agents, thyroid medications, etc.)
- Self-reported neurological or psychological disorder
- Self-reported claustrophobia or discomfort with mock fMRI training
- Self-reported history of head injury resulting in loss of consciousness for more than 10 minutes
- Contraindications to MRI, including pacemaker, aneurysm clip, neurostimulator, cochlear implant, metal in eyes, steel worker, other implants
- Self-reported previous metabolic/weight loss surgery
- Self-reported allergy to ingredient used in the study drinks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
May 28, 2026
First Posted
June 10, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
July 1, 2029
Last Updated
June 10, 2026
Record last verified: 2026-06